The US antitrust agencies’ continued focus on transactions in the health care industry has triggered recent high-profile merger investigations and enforcement actions. Organizations considering a vertical health care merger should carefully analyze and be prepared to address any competition implications to minimize the risk that antitrust issues will impede the transaction.
Read the full article: Antitrust Analysis of Vertical Health Care Mergers //
Source: https://www.reuters.com/practical-law-the-journal/transactional/antitrust-analysis-vertical-health-care-mergers-2024-07-01/